Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Artal Group S.A. (CIK 1053906) reported $931.1M across 2 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: CAVA ($510.7M, 54.85%), LXRX ($420.4M, 45.15%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CAVA | Cava Group Inc | $510.7M | 54.85% | 6.5M | Trimmed |
| 2 | LXRX | Lexicon Pharmaceuticals Inc | $420.4M | 45.15% | 175.2M | Added |
Source: SEC Form 13F filings · as of 2026-06-30